State Street SPDR S&P Biotech ETF XBI
Set alert
155.34 USD +3.28 +2.16%
As of Nov 3, 2:09 PM ET
152.83 Day range 156.92
106.30 52-week range 169.89
- YTD
- +27.40%
- 1 year
- +41.39%
- Open
- 152.96
- Prev close
- 152.05
- Mkt cap
- 7.95B
- Vol
- 3.61M
- Avg vol
- 8.95M
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 152.83
- High
- 156.92
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 156.60
- 200-d avg
- 141.64
- 1y target
- 0.00
1D chart
Signals (61)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | 2:06 PM | 3 minutes ago |
| SMA: Bearish | 1:48 PM | 21 minutes ago |
| SMA: Bearish | 1:48 PM | 21 minutes ago |
| SMA: Bullish | 1:47 PM | 22 minutes ago |
| SMA: Bearish | 1:45 PM | 24 minutes ago |
| SMA: Bullish | 1:43 PM | 26 minutes ago |
| SMA: Bearish | 1:39 PM | 30 minutes ago |
| MACD: Sell Signal | 1:37 PM | 32 minutes ago |
| MACD: Buy Signal | 1:33 PM | 36 minutes ago |
| MACD: Sell Signal | 1:18 PM | 51 minutes ago |
| RSI: Overbought | 1:12 PM | 57 minutes ago |
| RSI: Overbought | 1:09 PM | 1 hour ago |
| SMA: Bullish | 1:02 PM | 1 hour ago |
| SMA: Bullish | 12:59 PM | 1 hour ago |
| SMA: Bullish | 12:51 PM | 1 hour ago |
| SMA: Bearish | 12:50 PM | 1 hour ago |
| SMA: Bullish | 12:49 PM | 1 hour ago |
| MACD: Buy Signal | 12:49 PM | 1 hour ago |
| MACD: Sell Signal | 12:33 PM | 1 hour ago |
| MACD: Buy Signal | 12:31 PM | 1 hour ago |
Newest 20 of 61.
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 156.60
- 200-day average
- 141.64
Next earnings
Consensus EPS estimate 0.00.
About State Street SPDR S&P Biotech ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
News
- Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge
- Regeneron Surges 13.55%: Here's What It Means for Your Health Care ETFs
- ETFs That You May Consider Amid a Strengthening Biotech Outlook
- Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)?
- Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy?
- Why $55 Million Flowed Into a Triple-Leveraged Biotech ETF Worth Less Than $600 Million
- SPDR S&P Biotech ETF $XBI Stock Sold by Banque Pictet & Cie SA
- Traders Purchase Large Volume of Call Options on SPDR S&P Biotech ETF (NYSEARCA:XBI)
- From Laggard to Leader: The Surprising Comeback of Healthcare
- Biotech's Rebound Reality: Surging M&A Deals Meet Deep Retail Skepticism
Your note
Sign in to keep a note on XBI — it syncs with the Stock Master app.